Insmed Cash Provided by (Used in) Financing Activity, Including Discontinued Operation decreased by 12.8% to $29.51M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 1.8%, from $29.00M to $29.51M. Over 4 years (FY 2021 to FY 2025), Cash Provided by (Used in) Financing Activity, Including Discontinued Operation shows an upward trend with a 11.7% CAGR.
Negative values often indicate significant share buybacks or debt repayment, while positive values suggest new capital raising or increased borrowing.
The total net cash flow resulting from all financing activities, including proceeds from debt issuance, share repurchase...
Standard line item in the Statement of Cash Flows for all public companies.
other_net_cash_provided_by_used_in_financing_activities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $597.60M | $2.54M | $5.71M | $6.46M | $6.31M | $37.12M | $743.39M | -$399.00K | $44.33M | $1.25M | $123.26M | $3.02M | $781.49M | $397.20M | $159.31M | $29.00M | $857.81M | $33.41M | $33.86M | $29.51M |
| QoQ Change | — | -99.6% | +125.2% | +13.1% | -2.3% | +488.1% | >999% | -100.1% | >999% | -97.2% | >999% | -97.5% | >999% | -49.2% | -59.9% | -81.8% | >999% | -96.1% | +1.3% | -12.8% |
| YoY Change | — | — | — | — | -98.9% | >999% | >999% | -106.2% | +602.4% | -96.6% | -83.4% | +857.4% | >999% | >999% | +29.2% | +859.6% | +9.8% | -91.6% | -78.7% | +1.8% |